lysergic acid has been researched along with Migraine Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
| FRIEDMAN, AP; LOSIN, S | 1 |
| LEIGH, WE | 1 |
| CALLEJA CANELAS, JL; DOMINGUEZ LAZARO, AR; PEREZ GUERRERO, J; SASTRE CASTILLO, A | 1 |
| DESILVESTRI, A; PIOVELLA, C | 1 |
| SICUTERI, F | 4 |
| CROWTHER, DL | 1 |
| ABRAMSON, HA | 1 |
| Cerletti, A | 1 |
12 other study(ies) available for lysergic acid and Migraine Disorders
| Article | Year |
|---|---|
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
Topics: Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches | 1961 |
The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
Topics: Cardiovascular Agents; Ergot Alkaloids; Lysergic Acid; Methysergide; Migraine Disorders; Serotonin Antagonists; Vascular Headaches | 1963 |
[UML-491 (1-methyl-D-lysergic acid butanolamide) in the prevention and treatment of migraine and other types of headache].
Topics: Biomedical Research; Headache; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Serotonin | 1962 |
[INTRAVASCULAR ERYTHROCYTE AGGREGATION AND D-1 METHYL-LYSERGIC ACID BUTANOLAMIDE (DESERRIL OR UML 491)].
Topics: Blood Circulation; Bronchopneumonia; Cholangitis; Ergot Alkaloids; Erythrocyte Aggregation; Erythrocytes; Hepatitis; Hepatitis A; Kidney Diseases; Liver Cirrhosis; Lysergic Acid; Methysergide; Migraine Disorders; Neoplasms; Pharmacology; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Serotonin; Tonsillitis | 1963 |
PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
Topics: Biochemical Phenomena; Biochemistry; Electroencephalography; Ergot Alkaloids; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Urine | 1963 |
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
Topics: Analgesics; Ergot Alkaloids; Facial Neuralgia; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Rhinitis, Allergic, Seasonal; Selective Serotonin Reuptake Inhibitors; Serotonin; Vascular Headaches | 1964 |
ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
Topics: Asthma; Autistic Disorder; Child; Hallucinogens; Humans; Hypersensitivity; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Pharmacology; Schizophrenia; Schizophrenia, Childhood; Selective Serotonin Reuptake Inhibitors; Serotonin; Toxicology | 1964 |
Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
Topics: Anticonvulsants; Epilepsy; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Serotonin; Serotonin Antagonists | 1960 |
Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
Topics: Analgesics; Lysergic Acid; Lysergic Acid Diethylamide; Migraine Disorders; Serotonin | 1959 |
[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
Topics: Anencephaly; Epilepsy; Headache; Lysergic Acid; Lysergic Acid Diethylamide; Migraine Disorders | 1960 |
Ramifications of ergot research and their impact of the treatment of migraine.
Topics: Ergot Alkaloids; Humans; Lysergic Acid; Migraine Disorders | 1974 |